Polymyxin B immobilized column is effective for hydrochloric acid-induced lung injury in rats

European Journal of Pharmacology

Volumn 535, Issue 1-3, 2006, Pages 270-279

  Tsushima, Kenji ^a   Koizumi, Tomonobu ^a   Yoshikawa, Sumiko ^a   Obata, Toru ^b   Kubo, Keishi ^a  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Anandamide; Direct hemoperfusion using polymyxin B immobilized column; Growth related oncogene cytokine induced neutrophils chemoattractant 1; Hydrochloric acid induced lung injury; Neutrophil recruitment

Indexed keywords

ALBUMIN; CANNABINOID; CYTOKINE INDUCED NEUTROPHIL CHEMOATTRACTANT; HYDROCHLORIC ACID; POLYMYXIN B;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIAL GAS; ARTERIAL OXYGEN TENSION; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; FLOW RATE; GAS ANALYSIS; HEMOPERFUSION; LEUKOCYTE COUNT; LUNG INJURY; LUNG LAVAGE; MALE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; RAT; SYSTOLIC BLOOD PRESSURE;

ANIMALS; ANTI-BACTERIAL AGENTS; BLOOD PRESSURE; BRONCHOALVEOLAR LAVAGE FLUID; CELL COUNT; CHEMOKINES, CXC; HEMOPERFUSION; HYDROCHLORIC ACID; LEUKOCYTE COUNT; LUNG; LUNG DISEASES; MALE; NEUTROPHILS; POLYMYXIN B; RATS; RATS, SPRAGUE-DAWLEY; SURVIVAL RATE; TIME FACTORS;

EID: 33645411421     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2006.02.008     Document Type: Article

References (31)

1. R.C. Bone, R.A. Balk, A.M. Fein, T.M. Perl, R.P. Wenzel, H.D. Reines, R.W. Quenzer, T.J. Iberti, N. Macintyre, and R.M. Schein A second large controlled clinical study of E5, a monoclonal antibody to endotoxin: results of a prospective, multicenter, randomized, control trial. The E5 Sepsis Study group Crit. Care Med. 23 1995 994 1006
2. M.S. Carraway, K.E. Welty-Wolf, S.P. Kantarow, Y.C. Simonson, L.G. Que, T.K. Kishimoto, and C.A. Piantadosi Antibody to E- and L-selectin does not prevent lung injury or mortality in septic baboons Am. J. Respir. Crit. Care Med. 157 1998 938 949
3. J. Cohen, and J. Carlet INTERSEPT, an international, multicenter, placebo-controlled trial of monoclonal antibody to human tumor necrosis factor-alpha in patients with sepsis. International Sepsis Trial Study group Crit. Care Med. 24 1996 1431 1440
4. W.A. Devane, L. Hanus, A. Breuer, R.G. Pertwee, L.A. Stevenson, G. Griffin, D. Gibson, A. Mandelbaum, A. Etinger, and R. Mechoulam Isolation and structure of a brain constituent that binds to the cannabinoid receptor Science 258 1992 1946 1949
5. C.J. Fisher Jr., G.J. Slotman, S.M. Opal, J.P. Pribble, R.C. Bone, G. Emmanuel, D. Ng, D.C. Bloedow, and M.A. Catalano IL-1 RA Sepsis Syndrome Study Group. Initial evaluation of human recombinant interleukin-1 receptor antagonist in the treatment of sepsis syndrome: a randomized. Open label, placebo-controlled multicenter trial. The IL-1 RA Sepsis Syndrome Study group Crit. Care Med. 22 1994 12 22
6. K. Hanasawa, T. Tani, and M. Kodama New approach to endotoxic and septic shock by means of polymyxin B immobilized fiber Surg. Gynecol. Obstet. 168 1989 323 331
7. M. Iida, K. Watanabe, M. Tsurufumi, K. Takaishi, Y. Iizuka, and S. Tsurufui Level of neutrophil chemotactic factor CINC/gro, a member of the interleukin-8 family, associated with lipopolysaccharide-induced inflammation in rats Infect. Immun. 60 1992 1268 1272
8. H. Iwama, and T. Komatsu Effect of an endotoxin-removing column containing immobilized polymyxin B fiber in a patient with septic shock from gram-positive infection Acta Anaesthesiol. Scand. 42 1998 590 593
9. T.P. Kennedy, K.J. Johnson, R.G. Kunkel, P.A. Ward, P.R. Knight, and J.S. Finch Acute acid aspiration lung injury in the rat: biphasic pathogenesis Anesth. Analg. 69 1989 87 92
10. R. Kilbourn Nitric oxide synthase inhibitors-a mechanism-based treatment of septic shock Crit. Care Med. 27 1997 857 858
11. B.E. Kreger, D.E. Craven, and W.R. McCabe Gram-negative bacteremia: IV. Re-evaluation of clinical features and treatment in 612 patients Am. J. Med. 68 1980 344 355
12. Y.D. Luo, M.K. Patel, M.D. Wiederhold, and D.W. Ou Effects of cannabinoids and cocaine on the mitogen-induced transformations of lymphocytes of human and mouse origins Int. J. Immunopharmacol. 14 1992 49 56
13. M. Maccarrone, M. Bari, N. Battista, and A. Finazzi-Agro Endocannabinoid degradation, endotoxic shock and inflammation Curr. Drug Targets Inflamm. Allergy 1 2002 53 63
14. J.D. Palmer, and D. Rifkind Neutralization of the hemodynamic effects of endotoxin by polymyxin B Surg. Gynecol. Obstet. 138 1974 755 759
15. J.F. Pittet, R.C. Mackersie, T.R. Martin, and M.A. Matthay Biological markers of acute lung injury: prognostic and pathogenetic significance Am. J. Respir. Crit. Care Med. 155 1997 1187 1205
16. D. Rifkind, and J.D. Palmer Neutralization of endotoxin toxicity in chick embryos by antibiotics J. Bacteriol. 92 1996 815 819
17. H. Shoji, T. Tani, K. Hanasawa, and M. Kodama Extracorporeal endotoxin removal by polymyxin B immobilized fiber cartridge: designing and anti-endotoxin efficacy in the clinical application Therap. Apher. 2 1998 3 12
18. C. Sittipunt, K.P. Steinberg, J.T. Ruzinski, C. Myles, S. Zhu, R.B. Goodman, L.D. Hudson, S. Matalon, and T.R. Martin Nitric oxide and nitrosine in the lungs of patients with acute respiratory distress syndrome Am. J. Respir. Crit. Care Med. 163 2001 503 510
19. J.R. Snapper, G.R. Bernard, J.M. Hinson Jr., M. Hutchison, J.E. Loyd, M.L. Ogletree, and K.L. Brigham Endotoxemia-induced leukopenia in sheep: correlation with lung vascular permeability and hypoxemia but not with pulmonary hypertension Am. Rev. Respir. Dis. 127 1983 306 309
20. O. Takeuchi, K. Hoshino, T. Kawai, H. Sanjo, H. Takada, T. Ogawa, K. Takeda, and S. Akira Differential roles of TLR 2 and TLR 4 in recognition of gram-negative and gram-positive bacterial cell components Immunity 11 1999 443 451
21. T. Tani, T.M. Chang, M. Kodama, and M. Tsuchiya Endotoxin removed from hemoglobin solution using polymyxin-B immobilized fiber (PMX-F) followed by a new turbidometric endotoxin assay Biomater. Artif. Cells Immobil. Biotechnol. 20 1992 457 462
22. T. Tani, K. Hanasawa, Y. Endo, T. Yoshioka, M. Kodama, M. Kaneko, Y. Uchiyama, T. Akizawa, K. Takahasi, and K. Sugai Therapeutic apheresis for septic patients with organ dysfunction: hemoperfusion using a polymyxin B immobilized column Artif. Organs 22 1998 1038 1044
23. K. Tsushima, K. Kubo, T. Koizumi, K. Fujimoto, and K. Hora Direct hemoperfusion using a polymyxin B immobilized column improves acute respiratory distress syndrome J. Clin. Apher. 17 2002 97 102
24. S.J. van Deventer, H.R. Buller, J.W. ten Cate, A. Sturk, and W. Pauw Endotoxemia: an early predictor of septicaemia in febrile patients Lancet 2 1982 605 609
25. K. Varga, K. Lake, B.R. Martin, and G. Kunos Novel antagonist implicates the CB1 cannabinoid receptor in the hypotensive action of anandamide Eur. J. Pharmacol. 278 1995 279 283
26. J.A. Wagner, K. Varga, E.F. Ellis, B.A. Rzigalinski, B.R. Martin, and G. Kunos Activation of peripheral CB1 cannabinoid receptors in hemorrhagic shock Nature 322 1997 671 677
27. Y. Wang, Y. Liu, K.P. Sarker, M. Nakashima, T. Serizawa, A. Kishida, M. Akashi, M. Nakata, I. Kitajima, and I. Maruyama Polymyxin B binds to anandamide and inhibits its cytotoxic effect FEBS Lett. 470 2000 151 155
28. L.B. Ware, and M.A. Matthay The acute respiratory distress syndrome N. Engl. J. Med. 342 2000 1334 1349
29. A.P. Wheeler, W.D. Hardie, and G. Bernard Studies of anti-endotoxin antibody in preventing the physiologic changes of endotoxemia in awake sheep Am. Rev. Respir. Dis. 142 1990 775 781
30. H. Yamamoto, T. Koizumi, T. Kaneki, K. Fujimoto, K. Kubo, and T. Honda Direct hemoperfusion with polymyxin B-immobilized fiber improves shock and hypoxemia during endotoxemia in anesthetized sheep J. Endotoxin Res. 8 2002 419 426
31. E.J. Ziegler, J.A. McCutchan, J. Fierer, M.P. Grauser, J.C. Adoff, H. Douglas, and A.I. Braude Treatment of Gram-negative bacteremia and shock with human antiserum to a mutant Escherichia coli N. Engl. J. Med. 307 1982 1225 1230